Collectively, these findings underscore the potential of transcriptomic profiling to complement existing tools such as lactate, CRP, SOFA, and SIRS in refining patient triage and guiding personalized treatment strategies. The gene discussed is CRP; the disease is systemic inflammatory response syndrome.